Regulation and Legislation

CBD-Intel regulatory news in brief, 9th-15th January

15th January 2021 - Alerts roundup |

Asia
Australasia
Australia
California
China
EU
Europe
France
Italy
Japan
Mexico
Minnesota
Montana
Netherlands
New Jersey
New York
North America
South America
South Dakota
United States
Uruguay
Virginia
Wyoming
Regulation and Legislation
Alerts roundup

This week’s regulatory news in brief includes updates from the EU, France, Italy, Netherlands, Mexico, the US, Australia, China, Japan and Uruguay

Does the Canopy CO2 extraction lawsuit pose a threat to others in the industry?

15th January 2021 - Blog |

North America
United States
Policy and Politics
Regulation and Legislation
Blog

Canopy Growth’s quick action – filing a suit against GW Pharmaceuticals the day the patent was issued – coupled with the short time-frame for validity has left many worried that the company could go on an enforcement hunt and target any company using a CO2 method that it believes infringes on its intellectual property (IP). […]

Regulatory report: CBD product labelling – a US state-by-state analysis

14th January 2021 - Regulatory reports |

Alaska
California
Colorado
Florida
Indiana
Kentucky
Louisiana
Maine
Minnesota
New Jersey
New Mexico
New York
North America
Ohio
Oklahoma
Oregon
South Carolina
Texas
United States
Utah
Vermont
Virginia
West Virginia
Wisconsin
Regulation and Legislation
Regulatory reports

This report details the labelling requirements for CBD products of all US states that have enacted regulations and shows how manufacturers can create a versatile label to satisfy as many states’ regulations as possible

Regulatory report: Philippines

13th January 2021 - Regulatory reports |

Asia
Philippines
Regulation and Legislation
Regulatory reports

A debate on regulating cannabis for medicinal use is on the table in the Philippines, and several bills are currently being discussed. This report provides an overview of the current regulatory regime for CBD and cannabis in the country

Regulatory report: North Macedonia

11th January 2021 - Regulatory reports |

Europe
Macedonia
Regulation and Legislation
Regulatory reports

Unlike psychoactive cannabis, cultivation and processing of industrial hemp is not allowed in North Macedonia – however this may change. This report offers an overview of the current and likely future legal framework

CBD-Intel regulatory news in brief, 4th-8th January

8th January 2021 - Alerts roundup |

Alabama
Argentina
Asia
Australasia
Australia
Europe
Michigan
Nebraska
New Jersey
New York
North America
Philippines
South America
Texas
Ukraine
United Kingdom
United States
Wyoming
Regulation and Legislation
Alerts roundup

This week’s regulatory news in brief includes updates from the UK, Trinidad & Tobago, the US, Argentine, Australia, Philippines and Ukraine

What impact do Democrat victories in both of the Georgia senate seat elections have on chances for cannabis reform at the US federal level?

8th January 2021 - Blog |

North America
United States
Policy and Politics
Regulation and Legislation
US federal regulation
Blog

President elect Joe Biden still looks to be somewhat reluctant to too closely embrace cannabis reform as an issue. But effective control of the senate through victories by Raphael Warnock and Jon Ossoff in special run-off elections in the state of Georgia give Democrats 48 seats with two independents that generally vote democratic (and would […]

CBD-Intel global alerts database January

6th January 2021 - Alerts roundup |

Afghanistan
Africa
Alabama
Alaska
Albania
Algeria
Andorra
Argentina
Arizona
Arkansas
Armenia
Armenia
Asia
Australasia
Australia
Austria
Bahrain
Bangladesh
Belarus
Belgium
Bosnia and Herzegovina
Brazil
Bulgaria
California
Cambodia
Canada
Chile
China
Colombia
Colorado
Connecticut
Croatia
Cyprus
Czech Republic
Delaware
Democratic Republic of the Congo
Denmark
Ecuador
Egypt
England
Estonia
Ethiopia
EU
Europe
Finland
Florida
France
Georgia
Georgia
Germany
Greece
Hawaii
Honduras
Hong Kong
Hungary
Iceland
Idaho
Illinois
India
Indiana
Indonesia
Iowa
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Japan
Kansas
Kazakhstan
Kentucky
Kenya
Kosovo
Kuwait
Kyrgyzstan
Latvia
Lesotho
Libya
Lithuania
Louisiana
Luxemburg
Macedonia
Maine
Malaysia
Malta
Maryland
Massachusetts
Mauritania
Mexico
Michigan
Middle East
Minnesota
Mississippi
Missouri
Moldova
Monaco
Montana
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nebraska
Nepal
Netherlands
Nevada
New Hampshire
New Jersey
New Mexico
New York
New Zealand
Nigeria
North America
North Carolina
North Dakota
North Korea
Northern Ireland
Norway
Ohio
Oklahoma
Oman
Oregon
Pakistan
Paraguay
Pennsylvania
Peru
Philippines
Poland
Portugal
Puerto Rico
Qatar
Rhode Island
Romania
Russia
San Marino
Saudi Arabia
Scandinavia
Scotland
Serbia
Singapore
Slovakia
Slovenia
South Africa
South America
South Carolina
South Dakota
South Korea
Spain
Sri Lanka
Sudan
Sweden
Switzerland
Syria
Taiwan
Tanzania
Tennessee
Texas
Thailand
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Utah
Uzbekistan
Vatican City
Venezuela
Vermont
Vietnam
Virginia
Wales
Washington
Washington D.C.
West Virginia
Wisconsin
World
Wyoming
Yemen
Zimbabwe
Policy and Politics
Regulation and Legislation
Alerts roundup

All the stories from the CBD-Intel weekly global regulatory Live Alerts in one user-friendly database, updated every month.

This regulatory tool consolidates all of our global regulatory Live Alerts since they were launched in May 2019, collected in Excel database format, allowing you to filter information by date and country.

CBD-Intel regulatory news in brief, 19th-23rd December

23rd December 2020 - Alerts roundup |

Asia
Australasia
Australia
EU
Europe
Iceland
Ireland
Italy
Lithuania
New Jersey
North America
South Carolina
Thailand
Ukraine
United Kingdom
United States
Regulation and Legislation
Alerts roundup

This week’s regulatory news in brief includes updates from the UE, Iceland, Ireland, Italy, Lithuania, the UK, Ukraine, the US, Australia and Thailand

US regulatory tracker: Enacted regulation of CBD December 2020

21st December 2020 - Regulatory trackers |

California
Colorado
Connecticut
Florida
Georgia
Illinois
Massachusetts
Michigan
Nevada
New Jersey
North America
North Carolina
Ohio
Oregon
Pennsylvania
South Carolina
Tennessee
Texas
United States
Utah
Virginia
Washington
Regulation and Legislation
Regulatory trackers

Welcome to the CBD-Intel US enacted law regulatory tracker, updated each month. Within this interactive map gain insight into the enacted bills for 22 US states, with more state coverage coming very soon.

US regulatory tracker: Proposed state law December 2020

21st December 2020 - Regulatory trackers |

Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North America
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Puerto Rico
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
United States
Utah
Vermont
Virginia
Washington
Washington D.C.
West Virginia
Wisconsin
Wyoming
Policy and Politics
Regulation and Legislation
Regulatory trackers

Welcome to the new and improved CBD-Intel US state law regulatory tracker, updated every month and exclusively focused on state law. This interactive map allows you to search for states, zoom in and out from the map, view more than one regulatory area at a time, pan the map and select multiple states to compare regulations.

CBD-Intel regulatory news in brief, 12th-18th December

18th December 2020 - Alerts roundup |

Asia
Australasia
Belgium
Brazil
Canada
Europe
France
Ireland
Italy
Kentucky
Massachusetts
Mississippi
Netherlands
North America
Oregon
Philippines
South America
Switzerland
Thailand
United States
Uzbekistan
Regulation and Legislation
Alerts roundup

This week’s regulatory news in brief includes updates from Belgium, France, Ireland, Italy, Netherlands, Switzerland, Bermuda, the British Virgin Islands, Canada, Guam, the US, Australia, Brazil, Philippines, Thailand and Uzbekistan

Regulatory report: Cyprus

15th December 2020 - Regulatory reports |

Cyprus
Europe
Regulation and Legislation
Regulatory reports

CBD is considered a medicine in Cyprus and any CBD-infused product would be classified as a medicinal product. The report covers the current regulatory regime in place

Regulatory tracker: current global regulation of CBD January

15th December 2020 - Regulatory trackers |

Afghanistan
Africa
Alabama
Alaska
Albania
Algeria
Andorra
Argentina
Arizona
Arkansas
Armenia
Armenia
Asia
Australasia
Australia
Austria
Bahrain
Bangladesh
Belarus
Belgium
Bosnia and Herzegovina
Brazil
Bulgaria
California
Cambodia
Canada
Chile
China
Colombia
Colorado
Connecticut
Croatia
Cyprus
Czech Republic
Delaware
Democratic Republic of the Congo
Denmark
Ecuador
Egypt
England
Estonia
Ethiopia
EU
Europe
Finland
Florida
France
Georgia
Georgia
Germany
Greece
Hawaii
Honduras
Hong Kong
Hungary
Iceland
Idaho
Illinois
India
Indiana
Indonesia
Iowa
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Japan
Kansas
Kazakhstan
Kentucky
Kenya
Kosovo
Kuwait
Kyrgyzstan
Latvia
Libya
Lithuania
Louisiana
Luxemburg
Macedonia
Maine
Malaysia
Malta
Maryland
Massachusetts
Mauritania
Mexico
Michigan
Middle East
Minnesota
Mississippi
Missouri
Moldova
Monaco
Montana
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nebraska
Nepal
Netherlands
Nevada
New Hampshire
New Jersey
New Mexico
New York
New Zealand
Nigeria
North America
North Carolina
North Dakota
North Korea
Northern Ireland
Norway
Ohio
Oklahoma
Oman
Oregon
Pakistan
Pennsylvania
Peru
Philippines
Poland
Portugal
Qatar
Rhode Island
Romania
Russia
San Marino
Saudi Arabia
Scandinavia
Scotland
Serbia
Singapore
Slovakia
Slovenia
South Africa
South America
South Carolina
South Dakota
South Korea
Spain
Sri Lanka
Sudan
Sweden
Switzerland
Syria
Taiwan
Tanzania
Tennessee
Texas
Thailand
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Utah
Uzbekistan
Vatican City
Venezuela
Vermont
Vietnam
Virginia
Wales
Washington
Washington D.C.
West Virginia
Wisconsin
World
Wyoming
Yemen
Zimbabwe
Health
Marketing and Retailing
Policy and Politics
Regulation and Legislation
Regulatory trackers

CBD-Intel’s newly upgraded global regulatory tracker, updated every month, now offers a deeper analysis of each regulatory area.

Use the tabs at the top of the map to select a specific regulatory field and click on an individual country to bring up much more detail in the panel below, including links to legislation and CBD-Intel’s coverage of that market.

The key below the map indicates the level of regulation for the selected country and regulatory field based on our in-house analysis.

CBD-Intel regulatory news in brief, 5th-11th December

11th December 2020 - Alerts roundup |

Asia
Australasia
California
Ecuador
Europe
Illinois
Israel
Louisiana
Macedonia
Mexico
Michigan
Nebraska
New Zealand
North America
Pennsylvania
South Dakota
Switzerland
Tennessee
Thailand
United States
Regulation and Legislation
Alerts roundup

This week’s regulatory news in brief includes updates from North Macedonia, Switzerland, Mexico, the US, British Virgin Islands, Ecuador, Israel, New Zealand and Thailand

How far-reaching an impact could the CJEU Kanavape decision have?

11th December 2020 - Blog |

Europe
Companies
Health
Policy and Politics
Regulation and Legislation
Blog

The Court of Justice of the European Union’s (CJEU) decision in the Kanavape case will have a tremendous impact on the CBD industry in the European Union (EU). However, the breadth of its impact is not yet fully realised. A number of things must happen beforehand and it may come down to further court rulings before a […]

Regulatory report: Ecuador

10th December 2020 - Regulatory reports |

Ecuador
South America
Regulation and Legislation
Regulatory reports

This report provides a detailed overview of the current regulatory regime in place for hemp and CBD in Ecuador, as well as information on medical and recreational cannabis

Regulatory report: Ireland

9th December 2020 - Regulatory reports |

Europe
Ireland
Regulation and Legislation
Regulatory reports

Cannabis, THC and CBN are controlled substances in Ireland under the Misuse of Drugs Act, but CBD and CBG are not. This report offers an overview of the current regime in Ireland

CBD-Intel regulatory news in brief, 28th November-4th December

4th December 2020 - Alerts roundup |

Arizona
Australasia
Belgium
Colombia
Costa Rica
Cyprus
Denmark
EU
Europe
France
Ireland
Italy
New York
New Zealand
Slovakia
South America
Spain
Thailand
United States
Regulation and Legislation
Alerts roundup

This week’s regulatory news in brief includes updates from Belgium, Cyprus, the EU, Denmark, France, Ireland, Italy, Slovakia, Spain, the US, Colombia, Costa Rica, New Zealand and Thailand

What does the European Commissions (EC)’s change in opinion on CBD as a narcotic mean?

4th December 2020 - Blog |

Europe
Companies
Health
Policy and Politics
Regulation and Legislation
Blog

The announcement is a full reversal from the EC on a position that many found surprising in the first place. It marks a stellar period for the regulation of CBD and other cannabinoids with major decisions in their favour at the Court of Justice of the European Union, United Nations and now the EC. The […]

CBD-Intel regulatory news in brief, 21st-27th November

27th November 2020 - Alerts roundup |

Africa
Asia
Belgium
California
EU
Europe
France
Georgia
Germany
Iowa
Israel
Italy
Lithuania
Netherlands
New Jersey
North America
North Carolina
Poland
South Africa
South Dakota
Spain
Thailand
United States
Zimbabwe
Regulation and Legislation
Alerts roundup

This week’s regulatory news in brief includes updates from the EU, Belgium, France, Germany, Italy, Lithuania, Netherlands, Poland, Spain, the US, Israel, South Africa, Thailand and Zimbabwe

What impact will Black Friday sales have on the CBD sector?

27th November 2020 - Blog |

World
Companies
Health
Marketing and Retailing
Policy and Politics
Regulation and Legislation
Technology and Innovation
Blog

Overall it seems the industry – particularly in Europe – is not expecting much from Black Friday sales. European companies appear to consider CBD products more as health products that are requirement purchases throughout the year as opposed to lifestyle products that might be purchased as a one off during a special sales event. The situation may be slightly different in […]

CBD-Intel regulatory news in brief, 14th-20th November

20th November 2020 - Alerts roundup |

Africa
Asia
Brazil
California
China
Costa Rica
Czech Republic
EU
Europe
France
Kansas
Kentucky
Minnesota
Namibia
Netherlands
New Jersey
North America
North Carolina
Oklahoma
South America
Spain
Switzerland
United Kingdom
United Kingdom
United States
Virginia
West Virginia
Wisconsin
Wyoming
Regulation and Legislation
Alerts roundup

This week’s regulatory news in brief includes updates from the EU, Czech Republic, France, Netherlands, Spain, Switzerland, the UK, Mexico, the US, Cayman Islands, Brazil, China Costa Rica and Namibia

How important is the CJEU decision on the Kanavape case?

20th November 2020 - Blog |

Europe
Companies
Health
Policy and Politics
Regulation and Legislation
Technology and Innovation
Blog

How important is the CJEU decision on the Kanavape case?  The judgement in favour of CBD from the Courts of Justice of the European Union (CJEU) will almost certainly have significant long-term consequences for the CBD industry in Europe. It will likely influence the European Commission (EC)’s further assessment of the question of whether CBD is […]